BC
SBBP

Broadfin Capital’s Strongbridge Biopharma plc. SBBP Stock Holding History

Broadfin Capital’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,578,003
Closed -$6.16M – 52
2019
Q3 		$6.16M Buy
2,578,003
+33,164
+1% +$89.1K 1.14% 23
2019
Q2 		$7.96M Sell
2,544,839
-247,210
-9% -$908K 1.73% 22
2019
Q1 		$13.9M Sell
2,792,049
-29,673
-1% -$146K 2.87% 11
2018
Q4 		$12.6M Buy
2,821,722
+258,626
+10% +$1.26M 1.66% 17
2018
Q3 		$12.4M Buy
2,563,096
+222,447
+10% +$1.14M 1.83% 20
2018
Q2 		$14M Sell
2,340,649
-453,103
-16% -$3.32M 2.21% 17
2018
Q1 		$24.7M Sell
2,793,752
-392,943
-12% -$2.94M 3.85% 8
2017
Q4 		$23.1M Buy
3,186,695
+299,900
+10% +$1.87M 3.78% 10
2017
Q3 		$19.9M Buy
2,886,795
+14,867
+0.5% +$103K 2.95% 13
2017
Q2 		$20.5M Sell
2,871,928
-109,778
-4% -$507K 2.49% 13
2017
Q1 		$14.2M Buy
2,981,706
+87,125
+3% +$267K 1.72% 21
2016
Q4 		$6.95M Buy
2,894,581
+1,237,875
+75% +$5.05M 0.77% 37
2016
Q3 		$8.65M Hold
1,656,706
– – 0.78% 42
2016
Q2 		$6.59M Buy
1,656,706
+1
+0% +$5 0.64% 41
2016
Q1 		$7.55M Hold
1,656,705
– – 0.73% 38
2015
Q4 		$10.9M Buy
+1,656,705
New +$11.9M 0.67% 38

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Broadfin Capital's SBBP Position: Q4 2019 in Review

Broadfin Capital sold out of Strongbridge Biopharma plc. (SBBP) in Q4 2019, closing a stake of 2,578,003 shares — an estimated $6.16M sold.

Broadfin Capital first reported a position in SBBP in Q4 2015 and held it in 16 quarters. The position peaked at $24.7M in Q1 2018. 58 funds tracked by Wall St. Rank hold SBBP as of Q4 2019.

  • Broadfin Capital reported no remaining Strongbridge Biopharma plc. position as of Q4 2019 after selling out during the quarter.
  • Broadfin Capital sold 2,578,003 Strongbridge Biopharma plc. shares in Q4 2019, an estimated $6.16M.
  • Broadfin Capital first reported a position in Strongbridge Biopharma plc. in Q4 2015 and held it in 16 quarters.
  • Broadfin Capital's Strongbridge Biopharma plc. position peaked at $24.7M in Q1 2018.
  • 58 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q4 2019.

Based on Broadfin Capital's 13F filing for Q4 2019, filed 14 Feb 2020.